UNSPSC 51282327: Erythromycin stearate

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO13.C18H36O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LXW024X05M, chemically known as stearic acid, compd. with erythromycin (1:1) but more generally known as erythromycin stearate, which bears US NIH Compound Identifier 12559. European Medicines Agency schedules Erythromycin stearate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01946MIG.

UNSPSC 51282327 Erythromycin stearate is a Commodity code that designates a specific antibiotic pharmaceutical product. State and local governments procure this code through pharmaceutical supply and warehouse contracts managed by health departments and public health agencies, often leveraging cooperative purchasing consortiums such as MMCAP Infuse to aggregate demand and negotiate pricing with authorized distributors. The work solicited under this code consists of reliable, scheduled supply of erythromycin stearate tablets or suspension formulations meeting USP standards, typically bundled with other antibiotic or infectious-disease medications in multi-product warehouse agreements. Issuing bodies include state departments of public health, county health departments, and community health agencies that stock antibiotics for treatment programs, emergency preparedness, or disease-prevention initiatives.

Recent activity shows Illinois Department of Public Health as the primary buyer on record, which awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 covering a 12-month initial term with two renewal options, though the products listed in that award (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) differ from erythromycin stearate itself. A second opportunity from June 2026 — Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems with a July 26, 2026 response deadline — also diverges in scope and product category. The code shows minimal recent solicitation activity explicitly requesting erythromycin stearate, and the opportunities found under this tag involve dissimilar pharmaceutical products, suggesting either sparse current demand or occasional misclassification at the issuing-agency level.